Previous close | 143.25 |
Open | 143.25 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 100.00 |
Expiry date | 2025-01-17 |
Day's range | 143.25 - 143.25 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investing.com -- There is a higher potential for downside than upside in Biogen Inc's (NASDAQ:BIIB) shares, UBS analysts said Thursday, lowering their price target on the stock from $234 to $202.
The Food and Drug Administration signed off on a new eczema drug from Eli Lilly. Is Eli Lilly stock a buy right now?